The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Perivascular microglia activation is a hallmark of inflammatory demyelination in multiple sclerosis (MS), but the mechanisms underlying microglia activation and specific strategies to attenuate their activation remain elusive. Here, we identify fibrinogen as a novel regulator of microglia activation and show that targeting of the interaction of fibrinogen with the microglia integrin receptor Mac-1 (alpha(M)beta(2), CD11b/CD18) is sufficient to suppress experimental autoimmune encephalomyelitis in mice that retain full coagulation function. We show that fibrinogen, which is deposited perivascularly in MS plaques, signals through Mac-1 and induces the differentiation of microglia to phagocytes via activation of Akt and Rho. Genetic disruption of fibrinogen-Mac-1 interaction in fibrinogen-gamma(390-396A) knock-in mice or pharmacologically impeding fibrinogen-Mac-1 interaction through intranasal delivery of a fibrinogen-derived inhibitory peptide (gamma(377-395)) attenuates microglia activation and suppresses relapsing paralysis. Because blocking fibrinogen-Mac-1 interactions affects the proinflammatory but not the procoagulant properties of fibrinogen, targeting the gamma(377-395) fibrinogen epitope could represent a potential therapeutic strategy for MS and other neuroinflammatory diseases associated with blood-brain barrier disruption and microglia activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Fibγ390-396A mice have reduced clinical scores and microglia activation in EAE. (A) Clinical scores of MOG35-55–immunized mice. Fibγ390-396A mice (blue triangles; n = 29) show statistically significant lower clinical scores (*, P < 0.01) than FibγWT control mice (black squares; n = 28). (B) Individual clinical scores from Fibγ390-396A and FibγWT mice on days 20 (average clinical score, 3.3 ± 0.22 for FibγWT [n = 19] vs. 2.1 ± 0.32 for Fibγ390-396A [n = 20]; P < 0.01) and 31 after immunization (average clinical score, 2.8 ± 0.25 for FibγWT [n = 15] vs. 1.5 ± 0.23 for Fibγ390-396A [n = 20]; P < 0.001). (C) Histological analysis of spinal cord sections stained with hematoxylin/eosin revealed increased inflammation in the FibγWT mice versus the Fibγ390-396A mice. (D) Survival curve of Fibγ390-396A and FibγWT mice after MOG35-55 immunization. Fibγ390-396A had a greater survival rate than the FibγWT mice. (E) Rotarod analysis of Fibγ390-396A and FibγWT mice on day 13. Fibγ390-396A significantly outperformed their wild-type counterparts in a behavioral test designed to assess motor skill function. n = 7 mice per group. **, P < 0.05. (F) Increased activation of IsoB4+ cells in FibγWT mice as compared with Fibγ390-396A mice. Bar, 58 μm. Data are represented as the mean clinical score and are mean ± SEM.](https://figures.cochat.ai/paper-figures/a0547757dbd947b08e158d353bae9525/the-fibrin-derived-377-395-peptide-inhibits-microglia-activation-and-suppresses-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fggγ390–396A knock-in mice, which express fully coagulable fibrinogen that selectively lacks the CD11b receptor binding site (Adams et al., 2007; Flick et al., 2004).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Adams et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Moreover, in vivo live imaging showed that BBB disruption provokes the immediate and focal activation of microglia (7).”
BackgroundNew Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“For peptide- recognizing integrin receptors, such as the RGD-recognizing αvβ3 and α5β1 integrins, both the peptide itself and antibodies against the peptide may inhibit integrin-mediated biological eff ects (49-52).”
BackgroundInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“The CD11c+ perivascular dendritic cells are responsible for the presentation of myelin antigens (58, 59).”
Background
Cited by
Items 201–300 of 344
Hristovska, I., Binette, A. P., Kumar, A., Wennström, M., Gaiteri, C., Karlsson, L., Strandberg, O. T., Janelidze, S., van Westen, D., Stomrud, E., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01081-7 · Cited by 26
Prasad, J. M., Negrón, O. A., Du, X., Mullins, E. S., Palumbo, J. S., Gilbertie, J. M., Höök, M., Grover, S. P., Pawliński, R., Mackman, N., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009837118 · Cited by 22
Self-citationActivation of the Coagulation Cascade as a Universal Danger Sign
Старикова, Э. А., Mammedova, J. T., Rubinstein, A., Av, S., & Kudryavtsev, I. V. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020108 · Cited by 22
Fibrinogen regulates lesion border‐forming reactive astrocyte properties after vascular damage
Conforti, P., Mezey, S. E., Nath, S., Chu, Y., Malik, S. C., Santamaría, J. C. M., Deshpande, S. S., Pous, L., Zieger, B., & Schachtrup, C. (2022) · Glia · doi:10.1002/glia.24166 · Cited by 21
Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
Wen, T., & Zhang, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1197094 · Cited by 21
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation
Wang, S., Reeves, B., & Pawliński, R. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30369-3 · Cited by 21
Moan, N. L., Baeten, K. M., Rafalski, V. A., Ryu, J. K., Coronado, P. E. R., Bédard, C., Syme, C. A., Davalos, D., & Akassoglou, K. (2015) · eNeuro · doi:10.1523/eneuro.0050-14.2015 · Cited by 22
Self-citationKaneider, N. C., Mosheimer, B. A., Günther, A., Feistritzer, C., & Wiedermann, C. J. (2010) · Thrombosis Journal · doi:10.1186/1477-9560-8-2 · Cited by 21
CCSVI and MS: no meaning, no fact
Baracchini, C., Atzori, M., & Gallo, P. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1101-2 · Cited by 21
Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β
Beck, K., & Schachtrup, K. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1228-0 · Cited by 20
Heterozygosity for Fibrinogen Results in Efficient Resolution of Kidney Ischemia Reperfusion Injury
Ajay, A. K., Saikumar, J., Bijol, V., & Vaidya, V. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045628 · Cited by 20
The immunology of blood: connecting the dots at the neurovascular interface
Akassoglou, K. (2020) · Nature Immunology · doi:10.1038/s41590-020-0671-z · Cited by 20
Self-citationSchaller-Paule, M. A., Yalachkov, Y., Steinmetz, H., Friedauer, L., Hattingen, E., Miesbach, W., Weber, F., Kirchmayr, K., Schaefer, J. H., & Foerch, C. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001150 · Cited by 20
Noel, R. L., Kugelman, T., Karakatsani, M. E., Shahriar, S., Willner, M. J., Jimenez, D. A., Choi, C. S., Niimi, Y., Ji, R., Agalliu, D., et al. (2026) · Communications Engineering · doi:10.1038/s44172-026-00597-5 · Cited by 22
Verbout, N. G., Yu, X., Healy, L. D., Phillips, K. G., Tucker, E. I., Gruber, A., McCarty, O. J. T., & Offner, H. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9558-8 · Cited by 21
Zeng, Y.-L., Du, Y., Xu, X., Wang, Y., Yu, S., Liu, T., Luo, S., Xiang, X., Liu, W., Chen, Y.-C., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101947 · Cited by 19
In vivo imaging of the neurovascular unit in CNS disease
Merlini, M., Davalos, D., & Akassoglou, K. (2012) · IntraVital · doi:10.4161/intv.22214 · Cited by 19
Self-citationXie, T., Vora, A., Mulcahey, P. J., Nanescu, S. E., Singh, M., Choi, D. S., Huang, J. K., Liu, C., Sanders, D. P., & Hahm, J. (2016) · ACS Nano · doi:10.1021/acsnano.6b03071 · Cited by 19
Defibrinogenation Ameliorates Retinal Microgliosis and Inflammation in A CX3CR1-Independent Manner
Sarker, B., Cardona, S. M., Church, K. A., Vanegas, D., Velazquez, P., Rorex, C., Rodriguez, D., Mendiola, A. S., Kern, T. S., Domingo, N. D., et al. (2022) · ASN NEURO · doi:10.1177/17590914221131446 · Cited by 20
Estelius, J., Lengqvist, J., Ossipova, E., Idborg, H., Maître, E. L., Andersson, M., Brundin, L., Khademi, M., Svenungsson, E., Jakobsson, P., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1846-6 · Cited by 18
Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis
Andersson, C., Kvist, P. H., McElhinney, K. E., Baylis, R. A., Gram, L. K., Pelzer, H., Lauritzen, B., Holm, T. L., Hogan, S. P., Wu, D. X.-Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128113 · Cited by 17
Dubaniewicz, M. T., Eles, J. R., Lam, S., Song, S., Cambi, F., Sun, D., Wellman, S. M., & Kozai, T. D. Y. (2021) · Journal of Neural Engineering · doi:10.1088/1741-2552/abe8f1 · Cited by 17
Shafreen, R. B., Lakshmi, S. A., Pandian, S. K., Kim, Y.-M., Deutsch, J., Katrich, E., & Gorinstein, S. (2021) · Molecules · doi:10.3390/molecules26216686 · Cited by 17
Multiple Roles of Peripheral Immune System in Modulating Ischemia/Hypoxia-Induced Neuroinflammation
Guo, L., & Zhu, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.752465 · Cited by 17
Fibrinogen and Neuroinflammation in the Neurovascular Unit in Stroke
Chen, Y.-C., Han, L., Zhu, D., & Guan, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s496433 · Cited by 18
Ptaszek, B., Teległów, A., Adamiak, J., Głodzik, J., Podsiadło, S., Mucha, D. K., Marchewka, J., Halski, T., & Mucha, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132833 · Cited by 16
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis
Abbadessa, G., Lavorgna, L., Treaba, C. A., Bonavita, S., & Mainero, C. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211039111 · Cited by 17
An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis
Gatto, A. D., Saviano, M., & Zaccaro, L. (2021) · Molecules · doi:10.3390/molecules26175227 · Cited by 16
Ochocinska, M. J., Zloković, B. V., Searson, P. C., Crowder, A. T., Kraig, R. P., Ljubimova, J. Y., Mainprize, T. G., Banks, W. A., Warren, R. Q., Kindzelski, A., et al. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0061-6 · Cited by 16
Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis
Ehling, R., Pauli, F. D., Lackner, P., Kuenz, B., Santner, W., Lutterotti, A., Gneiss, C., Hegen, H., Schocke, M., Deisenhammer, F., et al. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-25 · Cited by 15
Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease
Zhang, Y., Zhang, X., Liu, D., Wang, H., Pan, S., Wang, D., & Chen, X. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2628-4 · Cited by 16
Using antifibrinolytics to tackle neuroinflammation
Atsev, S., & Tomov, N. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284979 · Cited by 14
Thrombin generation and activity in multiple sclerosis
Jordan, K. R., Parra‐Izquierdo, I., Gruber, A., Shatzel, J. J., Pham, P. T., Sherman, L. S., McCarty, O. J. T., & Verbout, N. G. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00652-w · Cited by 14
Rayatpour, A., & Javan, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105441 · Cited by 14
Bolton, C., & Smith, P. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150716103629 · Cited by 15
Fibrinogen: A potential biomarker for predicting disease severity in multiple sclerosis.
Ahmad, U., & Frederiksen, J. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102509 · Cited by 13
Wang, Y., Li, X., Li, Z., Han, X., Li, G., Zhou, C., Gu, P., Zou, Y., Xiao, X., Jiang, Y., et al. (2025) · Advanced Materials · doi:10.1002/adma.202512265 · Cited by 14
Magnusson, P., Jauhiainen, S., Onyeogaziri, F., Lazzaroni, F., Conze, L. L., Laakkonen, J. P., Karam, N. L., Laakso, A., Niemela, M., Jahromi, B. R., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167139 · Cited by 13
Inflammation and Coagulation in Neurologic and Psychiatric Disorders
Khoury, R., & Chapman, J. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0044-1801824 · Cited by 13
Xia, W., Li, C., Yao, X., Chen, Y., Zhang, Y., & Hu, H. W. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02898-3 · Cited by 12
Fibrin-targeting molecular MRI in inflammatory CNS disorders
Lohmeier, J., Silva, R. V., Tietze, A., Taupitz, M., Kaneko, T., Prüß, H., Paul, F., Infante‐Duarte, C., Hamm, B., Caravan, P. D., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05807-8 · Cited by 13
Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma
Chan, J. P., Merlini, M., Gao, H.-X., Mendiola, A. S., Akassoglou, K., Rubenstein, J. L., & Ryu, J. K. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.12.010 · Cited by 12
Self-citationKohs, T. C. L., Fallon, M. E., Oseas, E., Healy, L. D., Tucker, E. I., Gailani, D., McCarty, O. J. T., Vandenbark, A. A., Offner, H., & Verbout, N. G. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01251-1 · Cited by 12
A T cell-binding fragment of fibrinogen can prevent autoimmunity
Takada, Y., Ono, Y., Sagusa, J., Mitsiades, C. S., Mitsiades, N., Tsai, J., He, Y., Maningding, E., Coleman, A., Ramirez-Maverakis, D., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.017 · Cited by 12
Teo, F., Kok, C. Y. L., Tan, M.-J., & Je, H. S. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.03.005 · Cited by 11
Anwar, M. M., Pérez‐Martínez, L., & Pedraza‐Alva, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2358446 · Cited by 11
Sachs, B. D., & Akassoglou, K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351273 · Cited by 13
Self-citationFibrinolysis Regulation: A Promising Approach to Promote Osteogenesis
Lu, H., Xiao, L., Wang, W., Li, X., Ma, Y., Zhang, Y., & Wang, X. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0222 · Cited by 12
The cortical NG2 ‐glia response to traumatic brain injury
Dean, T., Ghaemmaghami, J., Corso, J., & Gallo, V. (2023) · Glia · doi:10.1002/glia.24342 · Cited by 11
Plaschke, K., Brenner, T., Fiedler, M. O., Hölle, T., von der Forst, M., Wolf, R. C., Kopitz, J., Gebert, J. F., & Weigand, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115781 · Cited by 12
Abulaban, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ahmed, E., Alruwaili, M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70067 · Cited by 11
Coagulation takes center stage in inflammation
Akassoglou, K. (2015) · Blood · doi:10.1182/blood-2014-11-609222 · Cited by 11
Self-citationRivaroxaban ameliorates disease course in an animal model of multiple sclerosis
Merker, M., Eichler, S., Herrmann, A. M., Wiendl, H., Kleinschnitz, C., Göbel, K., & Meuth, S. G. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.08.013 · Cited by 11
Wang, X., Li, Y., Wang, Y., Feng, Q., Yang, P., & Qin, L. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576994 · Cited by 12
The emerging role of fibrin(ogen) in cardiovascular disease
Lan, H., Zhao, S., Xiong, Y., & Yan, X. (2024) · Inflammation Research · doi:10.1007/s00011-024-01916-2 · Cited by 10
Towards Treating Multiple Sclerosis Progression
Häusler, D., & Weber, M. S. (2024) · Pharmaceuticals · doi:10.3390/ph17111474 · Cited by 10
Traumatic Brain Injury and Alzheimer’s Disease: A Shared Neurovascular Hypothesis
Cognacq, G., Attwood, J. E., & DeLuca, G. C. (2025) · Neuroscience Insights · doi:10.1177/26331055251323292 · Cited by 11
Koudriavtseva, T., Stefanile, A., Fiorelli, M., Lapucci, C., Lorenzano, S., Zannino, S., Conti, L., D'Agosto, G., Pimpinelli, F., di Domenico, E., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.548604 · Cited by 7
Agomelatine Attenuates Isoflurane-Induced Inflammation and Damage in Brain Endothelial Cells
Cheng, F., Chang, H. C., Yan, F., Yang, A., Liu, J., & Liu, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s281582 · Cited by 10
Fibrinogen drives neuroinflammation and neuropathology in perioperative neurocognitive disorders
Wang, X., Jiang, S., Di, L., Li, S., Chen, H., Huang, P., Cao, T., Jin, W., & Huang, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115906 · Cited by 10
Unraveling coagulation factor–mediated cellular signaling
O’Donnell, J. S., Fleming, H., Noone, D., & Preston, R. J. S. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.06.019 · Cited by 9
Mac-1 Regulates IL-13 Activity in Macrophages by Directly Interacting with IL-13Rα1
Cao, C., Zhao, J., Doughty, E., Migliorini, M. M., Strickland, D. K., Kann, M. G., & Zhang, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645796 · Cited by 9
Availability of Fibrinogen/Albumin ratio in MS attack
Çiçekli, E., Sayan, S., & Kotan, D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103674 · Cited by 9
Li, W., Gu, W.-L., Li, Z.-H., Zhang, S., ao, P., Zhu, X.-B., Zhao, X., Zhang, X., Zhang, D., Huang, X., et al. (2023) · Protein and Peptide Letters · doi:10.2174/0929866530666230509140515 · Cited by 9
Zilkha‐Falb, R., Gurevich, M., Hayardeny, L., & Achiron, A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.007 · Cited by 9
Wang, H., Tan, X., Li, H., Li, S., Hu, Y., Kuang, Y., Zhou, J., Zeng, D., Mei, L., Li, J., et al. (2026) · Dental Research · doi:10.1016/j.dtrs.2026.100026 · Cited by 9
Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer’s Disease
Merlini, M., Sözmen, E. G., Subramanian, K. S., Nana, A. L., Seeley, W. W., & Akassoglou, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_5 · Cited by 8
Self-citationTognatta, R., Merlini, M., Yan, Z., Schuck, R., Davalos, D., & Akassoglou, K. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100638 · Cited by 8
Self-citationJimenez, J. J., Jy, W., Mauro, L. M., Horstman, L. L., Fontana, V., & Ahn, Y. S. (2007) · American Journal of Hematology · doi:10.1002/ajh.21061 · Cited by 8
Laviv, Y., Kasper, B. S., & Kasper, E. M. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0837-9 · Cited by 9
Microvascular pathology in the spinal cord of severe spinal muscular atrophy patients
Allardyce, H., Lanz, H., Lawrence, B. D., Crawford, T. O., Sumner, C. J., & Parson, S. H. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02232-y · Cited by 7
Ghosh, S., Bhatti, G. K., Sharma, P. K., Kandimalla, R. J. L., Mastana, S. S., & Bhatti, J. S. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01434-5 · Cited by 9
Phan, N. M., Min, D. K., Mo, X. W., Im, P., & Kim, J. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166145 · Cited by 7
Aso, E., Serrano, A. L., Muñoz‐Cánoves, P., & Ferrer, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142928 · Cited by 7
A bloody brake on myelin repair
Nave, K., & Ehrenreich, H. (2017) · Nature · doi:10.1038/d41586-017-08232-2 · Cited by 7
Han, L., Song, Y., Xiang, W., Wang, Z., Wang, Y., Zhou, X., Zhu, D., & Guan, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111831 · Cited by 7
Lehikoinen, J., Strandin, T. M., Parantainen, J., Nurmi, K., Eklund, K. K., Rivera, F. J., Vaheri, A. I., & Tienari, P. J. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578432 · Cited by 7
Li, J., Zhang, J., Zou, L., Cao, M., Zhu, Z., Li, Y., Zhou, M., Fu, W., Dong, Z., Gao, H., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70033 · Cited by 6
Kantor, A. B., Rickert, M., Cheng, H., Flanagan, K., Salgotra, V., Suppahia, A., Ryu, J. K., Widboom, P., Warfield, J. R., Akassoglou, K., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03650-w · Cited by 6
Self-citationHemostasis Components as Therapeutic Targets in Autoimmune Demyelination
Abbadessa, G., Mainero, C., & Bonavita, S. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2532 · Cited by 6
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
Koudriavtseva, T., Lorenzano, S., Cellerino, M., Truglio, M., Fiorelli, M., Lapucci, C., D’Agosto, G., Conti, L., Stefanile, A., Zannino, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226616 · Cited by 5
Solomon, O. D., Villarreal, P. P., Domingo, N. D., Ochoa, L., Vanegas, D., Cardona, S. M., Cardona, A. E., Stephens, R., & Vargas, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-43208-5 · Cited by 5
Spencer, J. I., Crane, M., Pisa, M., Waldman, A. D., & DeLuca, G. C. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120056 · Cited by 5
Fibrinogen: connecting the blood circulatory system with CNS scar formation
Conforti, P., Santamaría, J. C. M., & Schachtrup, C. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1402479 · Cited by 4
Akassoglou, K., Agalliu, D., Chang, C. J., Davalos, D., Grutzendler, J., Hillman, E. M. C., Khakh, B. S., Kleinfeld, D., McGavern, D. B., Nelson, S. J., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00046 · Cited by 6
Self-citationLi, Y., Wang, S., Liu, P., Ma, J., Liu, X., & Yuan, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1140917 · Cited by 4
Macrophages and Microglia in Brain Malignancies
Riccadonna, C., & Paul, R. (2012) · InTech eBooks · doi:10.5772/35163 · Cited by 4
White Matter Injury After Experimental Intracerebral Hemorrhage
Wagner, K. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9123-1_11 · Cited by 4
Nakae, R., Murai, Y., & Yokobori, S. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87302-8_3-1 · Cited by 4
The Neuropathology of Progressive Multiple Sclerosis
Bø, L., Evangelou, N., & Tallantyre, E. C. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_4 · Cited by 4
Zhai, W., Qu, Y., Abuduxukuer, R., Zhang, K., Zhang, P., Tang, X., Zhang, H.-M., Wang, L., Yang, L.-C., Tan, S., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70247 · Cited by 3
Huang, Y., Yang, D.-P., Liao, S.-J., Guan, X., Zhou, F., Liu, Y., Wang, Y., & Zhang, Y. (2024) · Neuroreport · doi:10.1097/wnr.0000000000002083 · Cited by 3
Davalos, D., Akassoglou, K., & Cardona, A. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00041-2 · Cited by 3
Self-citationAge and Maturation Stage Linked Consequences of Fibrinogen on Human Oligodendroglia
Blaszczyk, G. J., Weng, C., Mohammadnia, A., Cui, Q., Giurleo, A., Groh, A. M. R., Plouffe, C., Sirois, J., Piscopo, V. E. C., Yaqubi, M., et al. (2026) · Journal of Neuroscience Research · doi:10.1002/jnr.70120 · Cited by 3
Imaging Microglia in the Central Nervous System: Past, Present and Future
Davalos, D., & Akassoglou, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_4 · Cited by 3
Self-citationTheranostic nanoparticles engineered for clinic and pharmaceutics
Singha, L. R., Ahmed, N., & Das, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821712-2.00010-4 · Cited by 4
Nanotechnology: An Emerging Field in Protein Aggregation and Cancer Therapeutics
Jena, S., Mohanty, S., Ojha, M., Subham, K., & Jha, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-2516-9_11 · Cited by 4
Radabaugh, H. L., Keller, J. N., Radtke, C. H., Kunney, C., Karvelas, N., Chan, H. W., Brathaban, N., Meyer‐Franke, A., Casaletto, K. B., Zetterberg, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.27.684881 · Cited by 3
Self-citationFibrinogen triggers perivascular fibroblast activation in a mouse model of cortical ischemic stroke
Santamaría, J. C. M., Fehlberg, C., Conforti, P., Ness, J. N., Justiniano, F. G., Manzitti, P., Bucher, F., Lee, J. K., & Schachtrup, C. (2025) · iScience · doi:10.1016/j.isci.2025.113834 · Cited by 2
Halder, S. K., Sapkota, A., & Milner, R. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03759-6 · Cited by 2
Metadata
- Authors
- Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K.
- Affiliations
- University of California San Diego (US)
- Medical University of Vienna (AT)
- University of Cincinnati (US)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-03-05
- Volume
- 204
- Issue
- 3
- Pages
- 571-582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2137908
- OpenAlex
- W2142424019
- Cited by
- 335
- References
- 72
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 19 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS052189, P30NS047101, R01NS051470)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- fibrinogen, microglial activation, Mac-1, CD11b/CD18, multiple sclerosis, experimental autoimmune encephalomyelitis, inflammatory demyelination, Akt signaling, Rho GTPase signaling, blood-brain barrier disruption, neuroinflammation
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Female, Fibrin, Fibrinogen, Mice, Inbred C57BL, Molecular Sequence Data, Peptide Fragments, Macrophage-1 Antigen, Microglia, Multiple Sclerosis, Relapsing-Remitting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.